Clusters significantly enriched in CD158i-expressing cells were paucicellular in healthy donors compared with COVID-19 patients (Fig 3G), and the relative frequency of CD158i-expressing cells was lower in healthy donors, regardless of the expression of other KIR receptors (Fig 3H). This evidence concerns the gene KIR2DS4 and COVID-19.